• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Preparation of oral sustained-action preparations with a base of biologically degradable polymers. 2. Preparation of matrix tablets with a base of polylactic acid].

作者信息

Mank R, Kala H, Richter M

机构信息

Sektion Chemie, Wissenschaftsbereich Pharmazie, Humboldt-Universität zu Berlin.

出版信息

Pharmazie. 1989 May;44(5):328-30.

PMID:2772012
Abstract

It is reported on the preparation and investigation of matrix tablets on the basis of the polylactic acid. Caffeine and phenazone served as model drugs. The release values obtained were analyzed by the equations of Noyes-Whitney and of Higuchi. It was demonstrated, that the solubility and the grain size of the drugs, their content in the tablets and an addition of Heweten 12 have an influence of the release of the drugs. In in vitro-investigations can be shown a hydrolytic degradation of the polymer, but not an enzymatic degradation.

摘要

相似文献

1
[Preparation of oral sustained-action preparations with a base of biologically degradable polymers. 2. Preparation of matrix tablets with a base of polylactic acid].
Pharmazie. 1989 May;44(5):328-30.
2
[Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
Pharmazie. 1989 Aug;44(8):545-7.
3
[Preparation of peroral sustained release drug forms on a base of biodegradable polymers. 1. Preparation and characterization of polylactic acid].基于可生物降解聚合物的口服缓释药物剂型的制备。1. 聚乳酸的制备与表征
Pharmazie. 1989 Apr;44(4):276-9.
4
[Preparations of matrix tablets from a polyacrylate base].[基于聚丙烯酸酯基质的骨架片制剂]
Pharmazie. 1986 Jan;41(1):42-4.
5
[Preparation of peroral delayed-action drug forms using biological polymers as the base. 4. Preparation of erosion tablets with a base of starch hydrolysis products].[以生物聚合物为基质制备口服缓释药物剂型。4. 以淀粉水解产物为基质制备溶蚀片]
Pharmazie. 1989 Sep;44(9):617-8.
6
[Preparations of preoral sustained-release preparations with a biological polymer base. 5 (correct title supplied from Table of Contents)].
Pharmazie. 1990 Jul;45(8):594-5.
7
Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics.
Chem Pharm Bull (Tokyo). 1982 Jul;30(7):2621-8. doi: 10.1248/cpb.30.2621.
8
Preparation of polylactic acid microcapsules containing ciprofloxacin.含环丙沙星聚乳酸微胶囊的制备
J Microencapsul. 1998 Jul-Aug;15(4):515-23. doi: 10.3109/02652049809006877.
9
[Compound erythromycin sustained release preparation and its in vitro release].复方红霉素缓释制剂及其体外释放
Yao Xue Xue Bao. 2011 Nov;46(11):1385-9.
10
Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.壳聚糖-阴离子聚合物基质片延长药物释放的机制研究。
Int J Pharm. 2014 Dec 10;476(1-2):253-65. doi: 10.1016/j.ijpharm.2014.09.057. Epub 2014 Oct 5.

引用本文的文献

1
Sugar end-capped poly-D,L-lactides as excipients in oral sustained release tablets.糖封端聚-D,L-丙交酯作为口服缓释片的辅料
AAPS PharmSciTech. 2009;10(2):566-73. doi: 10.1208/s12249-009-9247-9. Epub 2009 May 9.